The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation

Augusto D'Onofrio; Stefano Salizzoni; Antonino S. Rubino; Laura Besola; Claudia Filippini; Ottavio Alfieri; Antonio Colombo; Marco Agrifoglio; Theodor Fischlein; Filippo Rapetto; Giuseppe Tarantini; Magnus Dalèn; Davide Gabbieri; Bart Meuris; Carlo Savini; Giuseppe Gatti; Marco Luigi Aiello; Fausto Biancari; Ugolino Livi; Pier Luigi Stefàno; Mauro Cassese; Bruno Borrello; Mauro Rinaldi; Carmelo Mignosa; Gino Gerosa

doi:10.1016/j.jtcvs.2015.11.041

The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation

Augusto D'Onofrio, Stefano Salizzoni, Antonino S. Rubino, Laura Besola, Claudia Filippini, Ottavio Alfieri, Antonio Colombo, Marco Agrifoglio, Theodor Fischlein, Filippo Rapetto, Giuseppe Tarantini, Magnus Dalèn, Davide Gabbieri, Bart Meuris, Carlo Savini, Giuseppe Gatti, Marco Luigi Aiello, Fausto Biancari, Ugolino Livi, Pier Luigi StefànoMauro Cassese, Bruno Borrello, Mauro Rinaldi, Carmelo Mignosa, Gino Gerosa

Research output: Contribution to journal › Article

Abstract

Objective Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are suitable alternatives to conventional surgery. The aim of this study is to compare early outcomes of patients undergoing TAVI and SU-AVR. Methods Data were analyzed on patients who underwent TAVI and patients who underwent SU-AVR. Two matched cohorts (TAVI vs SU-AVR) were created using propensity scores; all analyses were repeated for transapical TAVI and transfemoral TAVI, separately. Outcomes were defined according to Valve Academic Research Consortium-2 criteria. Results A total of 2177 patients were included in the analysis: 1885 (86.6%) treated with TAVI; 292 (13.4%) treated with SU-AVR. Mortality in unmatched TAVI and SU-AVR patients was 7.1% and 2.1%, respectively, at 30 days, and 12.9% and 4.6%, respectively, at 1 year. No differences were found in 30-day mortality in the 214 matched patient pairs (3.7% vs 2.3%; P =.4), but patients treated with TAVI showed a lower incidence of device success (85.9% vs 98.6%; P

Original language	English
Pages (from-to)	99 - 109
Number of pages	11
Journal	Journal of Thoracic and Cardiovascular Surgery
Volume	152
Issue number	1
DOIs	https://doi.org/10.1016/j.jtcvs.2015.11.041
Publication status	Published - Jul 1 2016

Keywords

aortic valve replacement
heart valve replacement
heart valve replacement sutureless
percutaneous
transapical

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jtcvs.2015.11.041

Fingerprint Dive into the research topics of 'The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation'. Together they form a unique fingerprint.

Cite this

D'Onofrio, A., Salizzoni, S., Rubino, A. S., Besola, L., Filippini, C., Alfieri, O., Colombo, A., Agrifoglio, M., Fischlein, T., Rapetto, F., Tarantini, G., Dalèn, M., Gabbieri, D., Meuris, B., Savini, C., Gatti, G., Aiello, M. L., Biancari, F., Livi, U., ... Gerosa, G. (2016). The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation. Journal of Thoracic and Cardiovascular Surgery, 152(1), 99 - 109. https://doi.org/10.1016/j.jtcvs.2015.11.041

The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation. / D'Onofrio, Augusto; Salizzoni, Stefano; Rubino, Antonino S.; Besola, Laura; Filippini, Claudia; Alfieri, Ottavio; Colombo, Antonio; Agrifoglio, Marco; Fischlein, Theodor; Rapetto, Filippo; Tarantini, Giuseppe; Dalèn, Magnus; Gabbieri, Davide; Meuris, Bart; Savini, Carlo; Gatti, Giuseppe; Aiello, Marco Luigi; Biancari, Fausto; Livi, Ugolino; Stefàno, Pier Luigi; Cassese, Mauro; Borrello, Bruno; Rinaldi, Mauro; Mignosa, Carmelo; Gerosa, Gino.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 152, No. 1, 01.07.2016, p. 99 - 109.

Research output: Contribution to journal › Article

D'Onofrio, A, Salizzoni, S, Rubino, AS, Besola, L, Filippini, C, Alfieri, O, Colombo, A, Agrifoglio, M, Fischlein, T, Rapetto, F, Tarantini, G, Dalèn, M, Gabbieri, D, Meuris, B, Savini, C, Gatti, G, Aiello, ML, Biancari, F, Livi, U, Stefàno, PL, Cassese, M, Borrello, B, Rinaldi, M, Mignosa, C & Gerosa, G 2016, 'The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation', Journal of Thoracic and Cardiovascular Surgery, vol. 152, no. 1, pp. 99 - 109. https://doi.org/10.1016/j.jtcvs.2015.11.041

D'Onofrio, Augusto ; Salizzoni, Stefano ; Rubino, Antonino S. ; Besola, Laura ; Filippini, Claudia ; Alfieri, Ottavio ; Colombo, Antonio ; Agrifoglio, Marco ; Fischlein, Theodor ; Rapetto, Filippo ; Tarantini, Giuseppe ; Dalèn, Magnus ; Gabbieri, Davide ; Meuris, Bart ; Savini, Carlo ; Gatti, Giuseppe ; Aiello, Marco Luigi ; Biancari, Fausto ; Livi, Ugolino ; Stefàno, Pier Luigi ; Cassese, Mauro ; Borrello, Bruno ; Rinaldi, Mauro ; Mignosa, Carmelo ; Gerosa, Gino. / The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation. In: Journal of Thoracic and Cardiovascular Surgery. 2016 ; Vol. 152, No. 1. pp. 99 - 109.

@article{38a20f1acd5542ecb5e5f74269353a6a,

title = "The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation",

abstract = "Objective Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are suitable alternatives to conventional surgery. The aim of this study is to compare early outcomes of patients undergoing TAVI and SU-AVR. Methods Data were analyzed on patients who underwent TAVI and patients who underwent SU-AVR. Two matched cohorts (TAVI vs SU-AVR) were created using propensity scores; all analyses were repeated for transapical TAVI and transfemoral TAVI, separately. Outcomes were defined according to Valve Academic Research Consortium-2 criteria. Results A total of 2177 patients were included in the analysis: 1885 (86.6%) treated with TAVI; 292 (13.4%) treated with SU-AVR. Mortality in unmatched TAVI and SU-AVR patients was 7.1% and 2.1%, respectively, at 30 days, and 12.9% and 4.6%, respectively, at 1 year. No differences were found in 30-day mortality in the 214 matched patient pairs (3.7% vs 2.3%; P =.4), but patients treated with TAVI showed a lower incidence of device success (85.9% vs 98.6%; P",

keywords = "aortic valve replacement, heart valve replacement, heart valve replacement sutureless, percutaneous, transapical",

author = "Augusto D'Onofrio and Stefano Salizzoni and Rubino, {Antonino S.} and Laura Besola and Claudia Filippini and Ottavio Alfieri and Antonio Colombo and Marco Agrifoglio and Theodor Fischlein and Filippo Rapetto and Giuseppe Tarantini and Magnus Dal{\`e}n and Davide Gabbieri and Bart Meuris and Carlo Savini and Giuseppe Gatti and Aiello, {Marco Luigi} and Fausto Biancari and Ugolino Livi and Stef{\`a}no, {Pier Luigi} and Mauro Cassese and Bruno Borrello and Mauro Rinaldi and Carmelo Mignosa and Gino Gerosa",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.jtcvs.2015.11.041",

language = "English",

volume = "152",

pages = "99 -- 109",

journal = "Journal of Thoracic and Cardiovascular Surgery",

issn = "0022-5223",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation

AU - D'Onofrio, Augusto

AU - Salizzoni, Stefano

AU - Rubino, Antonino S.

AU - Besola, Laura

AU - Filippini, Claudia

AU - Alfieri, Ottavio

AU - Colombo, Antonio

AU - Agrifoglio, Marco

AU - Fischlein, Theodor

AU - Rapetto, Filippo

AU - Tarantini, Giuseppe

AU - Dalèn, Magnus

AU - Gabbieri, Davide

AU - Meuris, Bart

AU - Savini, Carlo

AU - Gatti, Giuseppe

AU - Aiello, Marco Luigi

AU - Biancari, Fausto

AU - Livi, Ugolino

AU - Stefàno, Pier Luigi

AU - Cassese, Mauro

AU - Borrello, Bruno

AU - Rinaldi, Mauro

AU - Mignosa, Carmelo

AU - Gerosa, Gino

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objective Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are suitable alternatives to conventional surgery. The aim of this study is to compare early outcomes of patients undergoing TAVI and SU-AVR. Methods Data were analyzed on patients who underwent TAVI and patients who underwent SU-AVR. Two matched cohorts (TAVI vs SU-AVR) were created using propensity scores; all analyses were repeated for transapical TAVI and transfemoral TAVI, separately. Outcomes were defined according to Valve Academic Research Consortium-2 criteria. Results A total of 2177 patients were included in the analysis: 1885 (86.6%) treated with TAVI; 292 (13.4%) treated with SU-AVR. Mortality in unmatched TAVI and SU-AVR patients was 7.1% and 2.1%, respectively, at 30 days, and 12.9% and 4.6%, respectively, at 1 year. No differences were found in 30-day mortality in the 214 matched patient pairs (3.7% vs 2.3%; P =.4), but patients treated with TAVI showed a lower incidence of device success (85.9% vs 98.6%; P

AB - Objective Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are suitable alternatives to conventional surgery. The aim of this study is to compare early outcomes of patients undergoing TAVI and SU-AVR. Methods Data were analyzed on patients who underwent TAVI and patients who underwent SU-AVR. Two matched cohorts (TAVI vs SU-AVR) were created using propensity scores; all analyses were repeated for transapical TAVI and transfemoral TAVI, separately. Outcomes were defined according to Valve Academic Research Consortium-2 criteria. Results A total of 2177 patients were included in the analysis: 1885 (86.6%) treated with TAVI; 292 (13.4%) treated with SU-AVR. Mortality in unmatched TAVI and SU-AVR patients was 7.1% and 2.1%, respectively, at 30 days, and 12.9% and 4.6%, respectively, at 1 year. No differences were found in 30-day mortality in the 214 matched patient pairs (3.7% vs 2.3%; P =.4), but patients treated with TAVI showed a lower incidence of device success (85.9% vs 98.6%; P

KW - aortic valve replacement

KW - heart valve replacement

KW - heart valve replacement sutureless

KW - percutaneous

KW - transapical

UR - http://www.scopus.com/inward/record.url?scp=84958259866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958259866&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2015.11.041

DO - 10.1016/j.jtcvs.2015.11.041

M3 - Article

VL - 152

SP - 99

EP - 109

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -